Affinity Asset Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-75,000	Closed	-$3.77M	–	102
2024 Q1	$3.77M	Buy	75,000 +4,012	+6%	+$202K	0.47%	49
2023 Q4	$4.29M	Buy	70,988 +20,988	+42%	+$1.27M	0.78%	31
2023 Q3	$2.85M	Buy	+50,000	New	+$2.85M	0.8%	31